Clinical Trial

Long-Term Follow-up Protocol

Name: Long-Term Follow-up Protocol — clinical trial record (NCT04917887)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The main objective of this prospective, observational, long-term follow-up (LTFU) study is to evaluate the long-term safety profile of the gene therapy products evaluated by Krystal Biotech, Inc. which have a shared backbone of HSV-1, in participants who received at least one dose of investigational product (IP).

Trial Details

NCT Number	NCT04917887
Lead Sponsor	Krystal Biotech, Inc.
Conditions	Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa
Enrollment	50 participants
Start Date	2021-05-25
Primary Completion	2028-05-25 (estimated)
Study Completion	2028-05-25 (estimated)
Updated on ClinicalTrials.gov	2021-06-08